These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30333274)

  • 1. Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis.
    Wee Leng G; Mustafar R; Kamaruzaman L; Mohd R; Cader RA; Wei Yen K; Kiew Bing P
    Acta Med Indones; 2018 Jul; 50(3):237-243. PubMed ID: 30333274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin.
    Kaito H; Kamei K; Kikuchi E; Ogura M; Matsuoka K; Nagata M; Iijima K; Ito S
    Pediatr Nephrol; 2010 May; 25(5):957-9. PubMed ID: 20033219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
    El-Reshaid K; El-Reshaid W; Madda J
    Ren Fail; 2005; 27(5):523-30. PubMed ID: 16152989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J; Ehrich JH; Querfeld U
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
    Kolonko A; Piecha G; Więcek A
    Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab and low-dose cyclosporine combination therapy for steroid-resistant focal segmental glomerulosclerosis.
    Suyama K; Kawasaki Y; Miyazaki K; Kanno S; Ono A; Suzuki Y; Ohara S; Hosoya M
    Pediatr Int; 2016 Mar; 58(3):219-223. PubMed ID: 26275234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
    Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis.
    Ino A; Kaori S; Takei T; Nitta K
    CEN Case Rep; 2020 Aug; 9(3):195-199. PubMed ID: 31997159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab.
    Marasà M; Cravedi P; Ruggiero B; Ruggenenti P
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25155494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis.
    Jayaraman VK; Thomas M
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26887886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of focal segmental glomerulosclerosis with nephrotic syndrome after hematopoietic stem cell transplantatation for aplastic anemia].
    Fuyama M; Ikeda H; Isoyama K
    Nihon Jinzo Gakkai Shi; 2013; 55(1):83-9. PubMed ID: 23461215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
    Chishti AS; Sorof JM; Brewer ED; Kale AS
    Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive treatment in primary focal segmental glomerulosclerosis.
    Xu S; Xu G; Zeng L
    J Nephrol; 2012; 25(5):626-35. PubMed ID: 22344540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study.
    Soliman AR; Maamoun H; Soliman H; Ahmed RM
    Rom J Intern Med; 2021 Jun; 59(2):127-133. PubMed ID: 33565308
    [No Abstract]   [Full Text] [Related]  

  • 16. A partial response to abatacept in a patient with steroid resistant focal segmental glomerulosclerosis.
    Soyaltın E; Demir BK; Alparslan C; Çamlar SA; Alaygut D; Yavaşcan Ö; Mutlubaş F
    Turk J Pediatr; 2020; 62(4):663-667. PubMed ID: 32779421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab.
    Suri M; Tran K; Sharma AP; Filler G; Grimmer J
    Int Urol Nephrol; 2008; 40(3):807-10. PubMed ID: 18491215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
    Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL
    Kidney Int; 1999 Dec; 56(6):2220-6. PubMed ID: 10594798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab in treatment of collapsing FSGS-A case series.
    Girimaji N; Bharati J; Nada R; Rathi M; Kohli HS; Ramachandran R
    Nephrology (Carlton); 2021 Feb; 26(2):134-141. PubMed ID: 32662534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy in patients with cyclosporin-resistant focal segmental glomerulosclerosis.
    Segarra Medrano A; Vila Presas J; Pou Clavé L; Majó Masferrer J; Camps Doménech J
    Nefrologia; 2011; 31(3):286-91. PubMed ID: 21468162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.